Biogaia is constantly expanding its base in regards of geographical markets.  But now a new area of use for proactive bacteria could be via the lungsystem (areosol ?) .

Danish Chr. Hansen Laboratories (listed on the Danish Stockexchange) have begun investigating the possible use of proactive bacteria (L. reuteri ) in fighting allegy and asthmatic disorders

Potentially this could open up totally new markets and liasions for Biogaia, who is already working with the advantages of bacteria in reducing allergy. :

the danish articles on the subject can be found here:

About Stengaard

BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂


Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.